Y2L-85054-79851
3 vaccinations
16 coded responses
28 check-ins
16 free-text entries
5 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 971 / OR
- Registered
- 2021-11-11
- Relationship
- Child or adolescent in my care
- Guardian
- 9PB-96345-07428
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-11
Registered in v-safe
-
2021-11-11
Dose 1 — Pfizer-BioNTech
- 2021-11-11
-
2021-11-12
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Fever · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-13
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-14
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Brain fog — Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Severe Mental fogMedDRA releases: 2024-11 · check-in free text available
-
2021-11-15
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Brain fog, Memory impairment — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Mental fogginess and difficulty remembering/following directionsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-18
Survey response — day 7, dose 1, dependentMedDRA: Abnormal behaviour, Cognitive disorder — Feeling: Good · Site: Redness, Itching · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Behavioral and cognitive shiftsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-25
Survey response — day 14, dose 1, dependentMedDRA: Disturbance in attention, Restlessness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Difficulty focusing and sitting stillMedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Survey response — day 21, dose 1, dependentMedDRA: Behaviour disorder, Office visit, Pruritus — Feeling: Good · Be unable to do their normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Behavioral challenges, itchiness · Healthcare visit (other): PCP visitMedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Report sent to call center — day 21, dose 1, dependentBe unable to do their normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-12-04
Dose 2 — Pfizer-BioNTech
- 2021-12-08
-
2021-12-09
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Abnormal behaviour — Feeling: Good · Site: Pain, Itching · Headache, NauseaFree text: Some behavior strugglesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Decreased appetite — Feeling: Good · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Loss of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-12-11
Health check-in — day 7, dose 2, dependentFeeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-18
Survey response — day 14, dose 2, dependentMedDRA: Brain fog, Unevaluable event — Feeling: Fair · Be unable to do their normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Impulse control, mental fogMedDRA releases: 2024-11 · check-in free text available
-
2021-12-18
Report sent to call center — day 14, dose 2, dependentBe unable to do their normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-22
Call successfulParticipant prefers to complete VAERS report online
- 2021-12-25
- 2022-01-01
- 2022-01-08
- 2022-01-15
-
2022-03-05
Survey response — 3 months, dose 2, dependentMedDRA: Cognitive disorder — Feeling: Fair · Be unable to do their normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Negative cognitive impactsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-05
Report sent to call center — 3 months, dose 2, dependentBe unable to do their normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-09
-
2022-06-02
Dose 3 — Pfizer-BioNTech
-
2022-06-05
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Behaviour disorder, Brain fog — Feeling: Fair · Site: Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Mental fog, behavioral challengesMedDRA releases: 2024-11 · check-in free text available
-
2022-06-06
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Behaviour disorder, Brain fog — Feeling: Good · Site: Redness, Itching · Fatigue or tirednessFree text: Behavioral challenges, mental fogMedDRA releases: 2024-11 · check-in free text available
-
2022-06-07
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Behaviour disorder, Brain fog — Feeling: Fair · Site: Redness · Fatigue or tirednessFree text: Mental fog and behavioral challengesMedDRA releases: 2024-11 · check-in free text available
-
2022-06-08
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Brain fog — Feeling: Good · Fatigue or tirednessFree text: Mental fogMedDRA releases: 2024-11 · check-in free text available
-
2022-06-09
Survey response — day 7, dose 3, dependentMedDRA: Behaviour disorder, Brain fog — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Mental fog, behavioral challengesMedDRA releases: 2024-11 · check-in free text available
- 2022-06-18
-
2022-06-23
Survey response — day 21, dose 3, dependentMedDRA: Behaviour disorder, Brain fog, Emotional disorder, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Mental fog, behavioral challenges, emotion regulation degradation · Healthcare visit (other): In person mental health servicesMedDRA releases: 2024-11 · check-in free text available
-
2022-06-23
Report sent to call center — day 21, dose 3, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-24
- 2022-06-30
- 2022-07-07
- 2022-07-19
-
2022-09-04
Survey response — 3 months, dose 3, dependentMedDRA: Abdominal discomfort, Headache, Migraine, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Frequent headaches/migraines with stomach upset · Healthcare visit (other): Primary care providerMedDRA releases: 2024-11 · check-in free text available
-
2022-09-04
Report sent to call center — 3 months, dose 3, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-06
- 2022-09-06
- 2022-09-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-11 | Pfizer-BioNTech | No |
| 2 | 2021-12-04 | Pfizer-BioNTech | No |
| 3 | 2022-06-02 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-03 | Unsuccessful | |
| 2021-12-18 | Successful 2021-12-22 |
Participant prefers to complete VAERS report online |
| 2022-03-05 | Unsuccessful | |
| 2022-06-23 | Unsuccessful | |
| 2022-09-04 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Severe Mental fog
Systemic reaction (other): Mental fogginess and difficulty remembering/following directions
Release 10 — day 7, dose 1, dependent
Systemic reaction (other): Behavioral and cognitive shifts
Release 10 — day 14, dose 1, dependent
Symptoms: Difficulty focusing and sitting still
Release 10 — day 21, dose 1, dependent
Release 10 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Some behavior struggles
Systemic reaction (other): Loss of appetite
Release 10 — day 14, dose 2, dependent
Symptoms: Impulse control, mental fog
Release 11 — 3 months, dose 2, dependent
Symptoms: Negative cognitive impacts
Release 11 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Mental fog, behavioral challenges
Systemic reaction (other): Behavioral challenges, mental fog
Systemic reaction (other): Mental fog and behavioral challenges
Systemic reaction (other): Mental fog
Release 12 — day 7, dose 3, dependent
Systemic reaction (other): Mental fog, behavioral challenges
Release 12 — day 21, dose 3, dependent
Symptoms: Mental fog, behavioral challenges, emotion regulation degradation
Healthcare visit (other): In person mental health services
Release 12 — 3 months, dose 3, dependent
Symptoms: Frequent headaches/migraines with stomach upset
Healthcare visit (other): Primary care provider
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abdominal discomfort | · | · | ✓ |
| SD | Behaviour disorder | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Disturbance in attention | · | · | ✓ |
| SD | Emotional disorder | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Pruritus | · | · | ✓ |
| SD | Restlessness | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Abnormal behaviour | · | · | ✓ |
| SRO | Behaviour disorder | · | · | ✓ |
| SRO | Brain fog | · | · | ✓ |
| SRO | Cognitive disorder | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Memory impairment | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release